1. Monash Health
  2. Monash Health research
  3. Articles
Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/35367
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMar A.en
dc.contributor.authorKerkemeyer K.L.S.en
dc.contributor.authorLai F.Y.X.en
dc.date.accessioned2021-05-14T11:56:49Zen
dc.date.available2021-05-14T11:56:49Zen
dc.date.copyright2020en
dc.date.created20200604en
dc.date.issued2020-06-04en
dc.identifier.citationAustralasian Journal of Dermatology. 61 (2) (pp 180-182), 2020. Date of Publication: 01 May 2020.en
dc.identifier.issn0004-8380en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/35367en
dc.languageenen
dc.publisherBlackwell Publishingen
dc.relation.ispartofAustralasian Journal of Dermatologyen
dc.subject.meshbetamethasone-
dc.subject.meshsitravatinib-
dc.subject.meshtislelizumab [Adverse Drug Reaction]-
dc.subject.meshtislelizumab-
dc.subject.meshlichen planus pemphigoides-
dc.subject.mesherythema-
dc.subject.meshhistopathology-
dc.subject.meshimmunofluorescence test-
dc.subject.meshinflammatory infiltrate-
dc.subject.meshlichen planus-
dc.subject.meshlung adenocarcinoma-
dc.subject.meshmaculopapular rash-
dc.subject.meshmetastasis-
dc.subject.meshmultiple cycle treatment-
dc.subject.meshparakeratosis-
dc.subject.meshpruritus-
dc.subject.meshrash-
dc.subject.meshstria-
dc.subject.meshbetamethasone-
dc.subject.meshbetamethasone/tp [Topical Drug Administration]-
dc.subject.meshcomplement component C3-
dc.subject.meshemollient agent-
dc.subject.meshemollient agent/tp [Topical Drug Administration]-
dc.subject.meshimmunoglobulin G-
dc.subject.meshpembrolizumab [Adverse Drug Reaction]-
dc.subject.meshpembrolizumab-
dc.subject.meshprednisolone [Oral Drug Administration]-
dc.subject.meshprednisolone-
dc.subject.meshsitravatinib-
dc.subject.meshsitravatinib [Oral Drug Administration]-
dc.subject.meshacanthosis-
dc.subject.meshaged-
dc.subject.meshblister-
dc.subject.meshdrug withdrawal-
dc.titleLichen planus pemphigoides during therapy with tislelizumab and sitravatinib in a patient with metastatic lung cancer.en
dc.typeLetteren
dc.identifier.affiliationDermatology-
dc.type.studyortrialCase series or case report-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/ajd.13214-
dc.publisher.placeAustraliaen
dc.identifier.pubmedid31808542 [http://www.ncbi.nlm.nih.gov/pubmed/?term=31808542]en
dc.identifier.source2003820512en
dc.identifier.institution(Kerkemeyer, Lai, Mar) Department of Dermatology, Monash Health, Clayton, VIC, Australiaen
dc.description.addressK.L.S. Kerkemeyer, Department of Dermatology, Monash Health, Clayton, VIC, Australia. E-mail: karolina.kerkemeyer@live.comen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2020 Elsevier B.V., All rights reserved.en
dc.identifier.authoremailKerkemeyer K.L.S.; karolina.kerkemeyer@live.comen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairetypeLetter-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
crisitem.author.deptDermatology-
Appears in Collections:Articles
Show simple item record

Page view(s)

10
checked on Sep 15, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.